Rethinking the Role of Advance Care Planning in the Context of Infectious Disease.
Sara M MoormanKathrin BoernerDeborah CarrPublished in: Journal of aging & social policy (2020)
Advance care planning (ACP) for medical decision-making at the end of life has developed around the expectation of death from long-term, progressive chronic illnesses. We reexamine advance care planning in light of the increased probability of death from COVID-19, an exemplar of death that occurs relatively quickly after disease onset. We draw several conclusions about ACP in the context of infectious diseases: interpersonal and sociostructural barriers to ACP are high; ACP is not well-oriented toward decision-making for treatment of an acute illness; and the U.S. health care system is not well positioned to fulfill patients' end of life preferences in a pandemic. Passing the peak of the crisis will reduce, but not eliminate, these problems.
Keyphrases
- advance care planning
- infectious diseases
- decision making
- coronavirus disease
- sars cov
- end stage renal disease
- ejection fraction
- healthcare
- mental health
- newly diagnosed
- multiple sclerosis
- chronic kidney disease
- public health
- prognostic factors
- drug induced
- respiratory failure
- aortic dissection
- patient reported
- replacement therapy